HIQA’s Strategic Blueprint for Health Care Excellence: Draft Corporate Plan 2025-2027

By João L. Carapinha

October 28, 2024

The HIQA Draft Corporate Plan 2025-2027 outlines the strategic direction and objectives of the Health Information and Quality Authority (HIQA) for the next three years. It serves as a roadmap for HIQA, emphasizing its commitment to promoting high standards in health and social care services across Ireland. Here are the key points from the document:

Foreword and Introduction

This plan marks HIQA’s 20th anniversary and reflects on its journey of continuous improvement, innovation, and collaboration in enhancing health and social care.

Strategic Direction

The HIQA Draft Corporate Plan 2025-2027 is designed to achieve tangible outcomes by 2027. It focuses on evidence-informed decision-making, standard setting, and regulation to ensure the best possible outcomes for health and social care.

Objectives and Priorities

HIQA aims to ensure that health and social care providers consistently deliver excellent standards of care and the best possible outcomes for service users. Key priorities include:
– Promoting safety and quality in health and social care services.
– Enhancing the health and welfare of the public by ensuring care is safe, effective, and respectful of individual rights.
– Responding to emerging challenges and opportunities in the health and social care landscape.

Stakeholder Engagement

HIQA developed the Draft Corporate Plan 2025-2027 through an extensive engagement programme with stakeholders, including patients, service users, policymakers, service providers, advocacy groups, HIQA staff, and the wider public.

Implementation and Monitoring

HIQA‘s Board and Executive Management Team will closely monitor and review the implementation of the Corporate Plan. A performance delivery agreement is in place between HIQA and the Department of Health to ensure alignment with Government priorities and external challenges.

Key Assumptions

The expansion of HIQA’s remit will occur on a gradual basis with sufficient time and additional resources.
– Extra resources will be allocated to support unplanned activities.
– Exchequer funding will adjust in accordance with changes to public sector pay scales and overall operating costs.

Human Rights and Sustainability

HIQA is dedicated to promoting human rights and valuing the needs of the communities it serves. The plan integrates sustainability and the UN Sustainable Development Goals into all relevant activities.

Long-term Outcomes

The plan establishes desired outcomes over the next three years while considering longer-term impacts, providing benchmarks for measuring success. Key outcomes include advancing HIQA’s vision and mission through improved health and social care standards and results.

Overall, the HIQA Draft Corporate Plan 2025-2027 is a comprehensive document that outlines a clear strategic direction, prioritizes stakeholder engagement, and emphasizes the importance of quality, safety, and sustainability in health and social care services.

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.